News on Bioline USA Inc from BioPortfolio.com http://www.BioPortfolio.com Consolidated Bioline USA Inc news from BioPortfolio.com Wed, 10 Feb 2010 07:52:42 GMT en Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039357&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039357&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039357&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039357&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057086%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039539&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039539&THISHREF=http://c.moreover.com/click/here.pl%3fz2538195209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039539&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039539&THISHREF=http://c.moreover.com/click/here.pl%3fz2538195209%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Mansell Promoted to Manager, U.S. Fleet Services for Amgen USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFleet Financials: Scientific Mgr, Research Mgmthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039470&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039470&THISHREF=http://c.moreover.com/click/here.pl%3fz2538128283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039470&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039470&THISHREF=http://c.moreover.com/click/here.pl%3fz2538128283%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNature: Biogen Idec Reports Full Year and Fourth Quarter 2009 Resultshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039358&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039358&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039358&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039358&THISHREF=http://c.moreover.com/click/here.pl%3fz2538057234%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Pharmaceutical Manufacturer Takes Full Advantage Malvern Particle Characterization System's Capabilitieshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039001&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537866566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039001&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039001&THISHREF=http://c.moreover.com/click/here.pl%3fz2537866566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Morphologi G3 adds new dimension to Solvay Pharmaceuticals R&Dhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038921&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038921&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038921&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038921&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837400%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Morphologi G3 adds new dimension to Solvay Pharmaceuticals Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038879&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038879&THISHREF=http://c.moreover.com/click/here.pl%3fz2537819971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038879&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038879&THISHREF=http://c.moreover.com/click/here.pl%3fz2537819971%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: 2/9/10 - YM BioSciences announces FDA clearance for two ongoing Phase II nimotuzumab trials into USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034544&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034544&THISHREF=http://c.moreover.com/click/here.pl%3fz2535849381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034544&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034544&THISHREF=http://c.moreover.com/click/here.pl%3fz2535849381%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradesh, Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037631&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037631&THISHREF=http://c.moreover.com/click/here.pl%3fz2537196525%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037631&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037631&THISHREF=http://c.moreover.com/click/here.pl%3fz2537196525%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037170&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037170&THISHREF=http://c.moreover.com/click/here.pl%3fz2536935949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037170&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037170&THISHREF=http://c.moreover.com/click/here.pl%3fz2536935949%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Google reduces fee to break Nexus One contracthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036444&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036444&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036444&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036444&THISHREF=http://c.moreover.com/click/here.pl%3fz2536619866%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Google cuts fee to break Nexus One contracthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032883&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032883&THISHREF=http://c.moreover.com/click/here.pl%3fz2534846868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032883&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032883&THISHREF=http://c.moreover.com/click/here.pl%3fz2534846868%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradesh, Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038374&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038374&THISHREF=http://c.moreover.com/click/here.pl%3fz2537584886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038374&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038374&THISHREF=http://c.moreover.com/click/here.pl%3fz2537584886%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: SOHM India Signs Strategic Alliance With Pharmaceutical Manufacturer in the Tax Exempt Area of Himachal Pradesh, Indiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037715&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037715&THISHREF=http://c.moreover.com/click/here.pl%3fz2537249084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037715&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bioline%20USA%20Inc&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037715&THISHREF=http://c.moreover.com/click/here.pl%3fz2537249084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: